Antidiabetic Drug Market Size By Application, Industry Analysis Report, Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Financial Impact Analysis)
ID : MRU_
53414 | Date :
Jan, 2023 | Pages :
180 | Region : Global |
Publisher : RI
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.
The Global Antidiabetic Drug Market size was xxx million USD with a CAGR xx % from 2018-2022. It will stretch to xxx million USD in 2023 with a CAGR of xx % from 2023-2030.
As the report focuses on global Antidiabetic Drug Market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the Market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces Market competition situation among the vendors and company profile, besides, Market price analysis and value chain features are covered in this report.
In Market segmentation by manufacturers, the report covers the following companies-
Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt
In Market segmentation by geographical regions, the report has analyzed the following regions- North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types covers:
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt–2
Thiazolodinediones
In Market segmentation by applications :
Type I Diabetes
Type II Diabetes
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Antidiabetic Drug Market for the forecast period 2023-2030?
• What are the driving forces in the Antidiabetic Drug Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Antidiabetic Drug industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antidiabetic Drug Market Size Growth Rate by Type (2020-2030)
1.3.2 Alpha-Glucosidase Inhibitors
1.3.3 Biguanides, Sulphonylureas
1.3.4 Glp-1 Agonist
1.3.5 Meglitinides
1.3.6 Dpp-4 Inhibitors
1.3.7 Sglt-2
1.3.8 Thiazolodinediones
1.4 Market Segment by Application
1.4.1 Global Antidiabetic Drug Market Share by Application (2020-2030)
1.4.2 Type I Diabetes
1.4.3 Type II Diabetes
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antidiabetic Drug Market Size
2.1.1 Global Antidiabetic Drug Revenue 2015-2030
2.1.2 Global Antidiabetic Drug Sales 2015-2030
2.2 Antidiabetic Drug Growth Rate by Regions
2.2.1 Global Antidiabetic Drug Sales by Regions 2015-2020
2.2.2 Global Antidiabetic Drug Revenue by Regions 2015-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antidiabetic Drug Sales by Manufacturers
3.1.1 Antidiabetic Drug Sales by Manufacturers 2015-2020
3.1.2 Antidiabetic Drug Sales Market Share by Manufacturers 2015-2020
3.2 Revenue by Manufacturers
3.2.1 Antidiabetic Drug Revenue by Manufacturers (2018-2022)
3.2.2 Antidiabetic Drug Revenue Share by Manufacturers (2018-2022)
3.2.3 Global Antidiabetic Drug Market Concentration Ratio (CR5 and HHI)
3.3 Antidiabetic Drug Price by Manufacturers
3.4 Key Manufacturers Antidiabetic Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antidiabetic Drug Market
3.6 Key Manufacturers Antidiabetic Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Alpha-Glucosidase Inhibitors Sales and Revenue (2018-2022)
4.1.2 Biguanides, Sulphonylureas Sales and Revenue (2018-2022)
4.1.3 Glp-1 Agonist Sales and Revenue (2018-2022)
4.1.4 Meglitinides Sales and Revenue (2018-2022)
4.1.5 Dpp-4 Inhibitors Sales and Revenue (2018-2022)
4.1.6 Sglt-2 Sales and Revenue (2018-2022)
4.1.7 Thiazolodinediones Sales and Revenue (2018-2022)
4.2 Global Antidiabetic Drug Sales Market Share by Type
4.3 Global Antidiabetic Drug Revenue Market Share by Type
4.4 Antidiabetic Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antidiabetic Drug Sales by Application
6 United States
6.1 United States Antidiabetic Drug Breakdown Data by Company
6.2 United States Antidiabetic Drug Breakdown Data by Type
6.3 United States Antidiabetic Drug Breakdown Data by Application
7 European Union
7.1 European Union Antidiabetic Drug Breakdown Data by Company
7.2 European Union Antidiabetic Drug Breakdown Data by Type
7.3 European Union Antidiabetic Drug Breakdown Data by Application
8 China
8.1 China Antidiabetic Drug Breakdown Data by Company
8.2 China Antidiabetic Drug Breakdown Data by Type
8.3 China Antidiabetic Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World Antidiabetic Drug Breakdown Data by Company
9.2 Rest of World Antidiabetic Drug Breakdown Data by Type
9.3 Rest of World Antidiabetic Drug Breakdown Data by Application
9.4 Rest of World Antidiabetic Drug Breakdown Data by Countries
9.4.1 Rest of World Antidiabetic Drug Sales by Countries
9.4.2 Rest of World Antidiabetic Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Sanofi-Aventis
10.1.1 Sanofi-Aventis Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antidiabetic Drug
10.1.4 Antidiabetic Drug Product Introduction
10.1.5 Sanofi-Aventis Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antidiabetic Drug
10.2.4 Antidiabetic Drug Product Introduction
10.2.5 Eli Lilly Recent Development
10.3 Oramed
10.3.1 Oramed Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antidiabetic Drug
10.3.4 Antidiabetic Drug Product Introduction
10.3.5 Oramed Recent Development
10.4 Takeda
10.4.1 Takeda Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antidiabetic Drug
10.4.4 Antidiabetic Drug Product Introduction
10.4.5 Takeda Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antidiabetic Drug
10.5.4 Antidiabetic Drug Product Introduction
10.5.5 Boehringer Ingelheim Recent Development
10.6 Novo Nordisk
10.6.1 Novo Nordisk Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Antidiabetic Drug
10.6.4 Antidiabetic Drug Product Introduction
10.6.5 Novo Nordisk Recent Development
10.7 Halozyme Therapeutics
10.7.1 Halozyme Therapeutics Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Antidiabetic Drug
10.7.4 Antidiabetic Drug Product Introduction
10.7.5 Halozyme Therapeutics Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Antidiabetic Drug
10.8.4 Antidiabetic Drug Product Introduction
10.8.5 Bristol-Myers Squibb Recent Development
10.9 Pfizer
10.9.1 Pfizer Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Antidiabetic Drug
10.9.4 Antidiabetic Drug Product Introduction
10.9.5 Pfizer Recent Development
10.10 Tonghua Dongbao
10.10.1 Tonghua Dongbao Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Antidiabetic Drug
10.10.4 Antidiabetic Drug Product Introduction
10.10.5 Tonghua Dongbao Recent Development
10.11 Biocon
10.12 Wockhardt
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antidiabetic Drug Sales Channels
11.2.2 Antidiabetic Drug Distributors
11.3 Antidiabetic Drug Customers
12 Market Forecast
12.1 Global Antidiabetic Drug Sales and Revenue Forecast 2020-2030
12.2 Global Antidiabetic Drug Sales Forecast by Type
12.3 Global Antidiabetic Drug Sales Forecast by Application
12.4 Antidiabetic Drug Forecast by Regions
12.4.1 Global Antidiabetic Drug Sales Forecast by Regions 2020-2030
12.4.2 Global Antidiabetic Drug Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
